On today’s episode of Danforth Dialogues, Dr. Valerie Montgomery Rice sits down with Dr. Albert Bourla, Chairman and CEO of Pfizer. Join us as we unpack the story behind the decision to invest billions in developing the MRNA vaccine for COVID-19. Dr. Bourla sheds light on the challenges faced, from overcoming skepticism about untested technology to rallying a diverse team in the face of a global crisis.
In this thought-provoking conversation, we delve into the intricacies of leadership during a pandemic, the critical role of partnerships with organizations like the NIH, and the profound impact on human lives. Dr. Bourla shares firsthand experiences, revealing the behind-the-scenes efforts that led to the successful development of the vaccine. We also explore the broader implications for the future of healthcare, the importance of combating vaccine misinformation, and the commitment to inclusivity in clinical trials and global vaccine distribution.
Stay tuned for a deep dive into the lessons learned, the challenges faced, and the visionary outlook on the intersection of science, leadership, and the collective pursuit of a healthier world.
CREDITS